Sinovac Biotech said on Saturday that its unit's Covid-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
It marks the second Covid-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.
Prior to the approvals, both vaccines have already been used in China's vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release.
The approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained, Sinovac said.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Taiwan releases train crash suspect on bond, prosecutors to appeal
Taiwan mourns after deadliest train disaster in decades
At least 51 dead as Taiwan train derails in tunnel
China under pressure after WHO chief revives lab leak theory
Taiwan pilot killed, another missing after fighter jets collide
Hong Kong's fragile coral reefs boosted by 3D printing
Biggest sandstorm in decade turns Beijing skies yellow
China punishes Donghai Airlines for crew's mid-air fight
China launches Covid-19 vaccination certificates for cross-border travel